Table 5.
Exposure (nSNPs) | Outcome | IVW | Weighted median | MR-Egger | MR-PRESSO | MR-Egger Intercept | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beta | P | Beta | P | Beta | P | Global test P | Raw beta | P | Corrected beta | P | Intercept | P | ||
AD (28) | GERD | −0.053 | 0.266 | 0.011 | 0.860 | −0.059 | 0.362 | 0.113 | −0.052 | 0.276 | — | — | 0.00034 | 0.879 |
GERD (24) | AD | 0.014 | 0.351 | −0.002 | 0.920 | −0.053 | 0.597 | 0.435 | 0.0136 | 0.361 | — | — | 0.0025 | 0.502 |
AD (28) | PUD | 0.036 | 0.651 | 0.144 | 0.211 | 0.071 | 0.504 | 0.113 | 0.036 | 0.60 | — | — | −0.002 | 0.612 |
PUD (8) | AD | 0.021 | 0.238 | 0.025 | 0.122 | 0.055 | 0.658 | 0.0104 | 0.021 | 0.277 | 0.0331 | 0.053 | −0.00291 | 0.770 |
AD (28) | PGM | −0.061 | 0.112 | −0.016 | 0.769 | −0.045 | 0.391 | 0.231 | −0.061 | 0.123 | — | — | −0.001 | 0.631 |
PGM (17) | AD | 0.023 | 0.322 | −0.005 | 0.837 | −0.148 | 0.199 | 0.017 | 0.023 | 0.337 | 0.009 | 0.661 | 0.007 | 0.133 |
AD (28) | Gastritis-Da | −0.085 | 0.267 | −0.101 | 0.273 | −0.173 | 0.098 | 0.034 | −0.085 | 0.277 | — | — | 0.0046 | 0.196 |
AD (28) | IBSa | 0.043 | 0.623 | 0.142 | 0.123 | −0.016 | 0.888 | 0.0012 | 0.043 | 0.626 | 0.010 | 0.892 | 0.0032 | 0.438 |
AD (28) | Diverticular | −0.055 | 0.597 | −0.214 | 0.105 | −0.12 | 0.397 | 0.094 | −0.055 | 0.601 | — | — | 0.0034 | 0.483 |
Diverticular (16) | AD | −0.001 | 0.883 | −0.001 | 0.905 | 0.007 | 0.811 | 0.316 | −0.001 | 0.884 | — | — | −0.00076 | 0.773 |
AD (28) | IBD | 0.254 | 0.104 | 0.365 | 0.094 | 0.277 | 0.231 | 0.327 | 0.254 | 0.115 | — | — | −0.00097 | 0.885 |
IBD (24) | AD | −0.0005 | 0.895 | −0.003 | 0.526 | 0.004 | 0.607 | 0.316 | −0.0005 | 0.895 | — | — | 0.00073 | 0.497 |
nSNP number of SNPs utilised as instrumental variables, SNP single-nucleotide polymorphism, AD Alzheimer’s disease, GERD gastroesophageal reflux disease, PUD peptic ulcer disease, PGM GWAS combining disease-diagnosis of PUD and/or GERD and/or medications for their treatments, Diverticular diverticular disease, IBS irritable bowel syndrome, IBD inflammatory bowel disease, IVW inverse variance weighted, P P value, MR-PRESSO Mendelian Randomization Pleiotropy RESidual Sum and Outlier, Gastritis-D gastritis-duodenitis.
aOnly one genome-wide significant SNPs available for IBS, and 3 for Gastritis-D, so we are unable to carry out MR using the traits as the exposure variable. Note spaces marked with a dash indicate that there were no outlier SNPs and hence there was no outlier corrected results in the MR-PRESSO analysis.